Search

everythinglearnresearchcommunity

for

Search:↓

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Most Latino farmworkers in the study had skin diseases, with fungal infections being the most common.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

Many patients on new leukemia drugs had mild to moderate skin reactions.

The Arabic Skindex-16 is a reliable and valid way to measure the impact of skin conditions on quality of life in Saudi patients.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Dermatologists found teledermatology useful and confidence-boosting for diagnosing skin conditions, but faced limitations like technical issues and prescription restrictions. Despite this, they saw its potential to improve access to skin care, especially in remote areas.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

A cat with skin bumps and itching had high blood fats and skin infections, which improved with diet and medication changes.

EGFR inhibitors can cause yellowish skin eruptions.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Many Iraqi patients had skin problems at the site where a vein was taken for heart surgery.

The paper concludes that elderly in India face unique skin challenges and need better dermatological care and awareness.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Older adults most often had skin infections and eczema at a hospital in Nepal.

A TP63 gene mutation causes significant hair loss and mild skin, nail, and tooth abnormalities.

Heptaminol may cause hair lightening in hemodialysis patients.

Most HIV patients in the study showed skin and mucous membrane issues, with oral thrush being the most common.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.